NCT06642142

Brief Summary

The goal of this observational study is to to evaluate the changes in cold sensitivity and the onset of sensory block after performing a thoracic ESP block. It reflects the time it takes for the local anaesthetic to spread into the paravertebral space leading to changes in cold sensitivity in the chest. The study population are patients undergoing simple quadrantectomy or partial resection with or without sentinel lymphnode removal, in the operating rooms of Santa Maria Goretti Hospital in Latina. This study is observational because it simply describes and records the effects of a procedure (the ESP block) on treated patients during a period of observation. Before surgery, unilateral thoracic ESP block (T4 level) with a sterile, ultrasound-guided technique will be performed. A timer will be started to mark the time for subsequent evaluations. At 1,3,5 and after every 5 minutes following the block up to 40 minutes or until induction of general anaesthesia, the cold sensitivity of the chest will be explored.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 7, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 15, 2024

Completed
23 days until next milestone

Study Start

First participant enrolled

November 7, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

November 8, 2024

Status Verified

November 1, 2024

Enrollment Period

11 months

First QC Date

October 7, 2024

Last Update Submit

November 7, 2024

Conditions

Keywords

ESPB

Outcome Measures

Primary Outcomes (10)

  • The onset of sensory block after thoracic ESP block after one minute

    Assessment of the onset, the extent and the evolution, as the time passes by, of sensory changes, described through absent or altered cold sensitivity on the thoracic dermatomeres, after performing thoracic (T4 level) ESPB.

    One minute after ESPB is performed

  • The onset of sensory block after thoracic ESP block after three minutes

    Assessment of the onset, the extent and the evolution, as the time passes by, of sensory changes, described through absent or altered cold sensitivity on the thoracic dermatomeres, after performing thoracic (T4 level) ESPB.

    3 minutes after ESPB is performed

  • The onset of sensory block after thoracic ESP block after five minutes

    Assessment of the onset, the extent and the evolution, as the time passes by, of sensory changes, described through absent or altered cold sensitivity on the thoracic dermatomeres, after performing thoracic (T4 level) ESPB.

    5 minutes after ESPB is performed

  • The onset of sensory block after thoracic ESP block after 10 minutes

    Assessment of the onset, the extent and the evolution, as the time passes by, of sensory changes, described through absent or altered cold sensitivity on the thoracic dermatomeres, after performing thoracic (T4 level) ESPB.

    10 minutes after ESPB is performed

  • The onset of sensory block after thoracic ESP block after 15 minutes

    Assessment of the onset, the extent and the evolution, as the time passes by, of sensory changes, described through absent or altered cold sensitivity on the thoracic dermatomeres, after performing thoracic (T4 level) ESPB.

    15 minutes after ESPB is performed

  • The onset of sensory block after thoracic ESP block after 20 minutes

    Assessment of the onset, the extent and the evolution, as the time passes by, of sensory changes, described through absent or altered cold sensitivity on the thoracic dermatomeres, after performing thoracic (T4 level) ESPB.

    20 minutes after ESPB is performed

  • The onset of sensory block after thoracic ESP block after 25 minutes

    Assessment of the onset, the extent and the evolution, as the time passes by, of sensory changes, described through absent or altered cold sensitivity on the thoracic dermatomeres, after performing thoracic (T4 level) ESPB.

    25 minutes after ESPB is performed

  • The onset of sensory block after thoracic ESP block after 30 minutes

    Assessment of the onset, the extent and the evolution, as the time passes by, of sensory changes, described through absent or altered cold sensitivity on the thoracic dermatomeres, after performing thoracic (T4 level) ESPB.

    30 minutes after ESPB is performed

  • The onset of sensory block after thoracic ESP block after 35 minutes

    Assessment of the onset, the extent and the evolution, as the time passes by, of sensory changes, described through absent or altered cold sensitivity on the thoracic dermatomeres, after performing thoracic (T4 level) ESPB.

    35 minutes after ESPB is performed

  • The onset of sensory block after thoracic ESP block after 40 minutes

    Assessment of the onset, the extent and the evolution, as the time passes by, of sensory changes, described through absent or altered cold sensitivity on the thoracic dermatomeres, after performing thoracic (T4 level) ESPB.

    40 minutes after ESPB is performed

Interventions

ESP blockPROCEDURE

The ESPB will be performed at the T4 level, monolaterally (according to the surgical side), with 30ml volume of 0.5% Ropivacaine injected with a 20-gauge, 50-mm-long needle. The technique used is the standard ultrasound-guided, sterile procedure. Soon after performing the block, a timer will be started to mark the time for subsequent evaluations. At 1,3,5 and after every 5 minutes following the block until 40 minutes or until general anaesthesia is induced, the cold sensitivity of the chest will be explored.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing ESP block for simple quadrantectomy and partial resection with or without lymphnode resection

You may qualify if:

  • Age ≥ 18 years.
  • ASA score I-II-III.
  • Schedule of breast surgery
  • Schedule of ESPB
  • Consent to the study

You may not qualify if:

  • Allergy to local anaesthetics
  • Cardiopathies, nephropathies, hepatopathies, central or peripheral neuropathies uncompensated
  • Infection at the injection site
  • Uncooperative patient
  • BMI \< 20, \> 40
  • Difficulty in visualising target structures or the LA spread (failure of technique)
  • Pregnancy status

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ospedale Santa Maria Goretti, Via Lucia Scaravelli

Latina, Italy, 04100, Italy

RECRUITING

Central Study Contacts

Alessandro De Cassai, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

October 7, 2024

First Posted

October 15, 2024

Study Start

November 7, 2024

Primary Completion

October 1, 2025

Study Completion

October 1, 2025

Last Updated

November 8, 2024

Record last verified: 2024-11

Locations